• 患者服务: 与癌共舞小助手
  • 微信号: yagw_help22

QQ登录

只需一步,快速开始

开启左侧

[基础知识] 给免疫治疗“减毒增效”的辅助药物(十二)--吸氢气或者补充辅酶Q10

[复制链接]
7862 1 自学自救 发表于 2025-4-12 15:18:57 |

马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。

您需要 登录 才可以下载或查看,没有账号?立即注册

x
《Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells, leading to better nivolumab outcomes in patients with lung cancer》
" v$ p/ ^- N% ^, E. Z) o( u# L3 @
8 b  ?: q; G3 H, N4 l3 P这是日本的一个O药联合或者不联合吸氢气治疗非小细胞肺癌的前瞻性随机对照试验。. y* m. ^" o' ^" l
" V* W4 K# G( z  p  R' Z
制氢机出气量等情况是这样:“The Hycellvator ET 100 (Helix Japan, Co., Ltd.) generates 1.67 l/ min hydrogen gas (hydrogen purity, 99.99%) by electrolysis. As measured by gas chromatography at Kureha Special Laboratory, the gas generated 680,000 ppm hydrogen gas and 320,000 ppm oxygen gas. Recently, hydrogen gas inhalation was used in patients with post-cardiac arrest syndrome, and adverse events were not observed”2 ~+ {8 ^) i- \  H

, \  \  d9 o7 B5 S0 R* z患者每天吸三个小时氢气。
6 L, O+ w8 p, v/ B" V9 j% ^
  o% e$ g8 Z1 E& ]9 {# h% I60个月的随访,临床试验结果是:“Kaplan-Meyer analysis showed that the HGN-treated patients had a significantly longer OS than those treated with NO (Fig. 1A). Median survival time (MST) for the HGN-treated patients was 28 months, a length that is approximately 3-fold longer than that for NO-treated patients (MST 9 months) (Fig. 1A).”- f( u. A8 x/ F2 n- P0 \' _# E0 q
1 X- j0 P" N  U! I
联合吸氢组的中位生存期是28月,不联合吸氢组的中位生存期是9个月。
' N- x9 T: h' Y3 J8 y3 x " A6 r) D# R! Z) u
研究者认为联合吸氢组疗效更好的原因是 “Hydrogen gas activates coenzyme Q10 to restore exhausted CD8+ T cells, especially PD-1+Tim3+terminal CD8+ T cells。”
% ?( h/ [; @1 k' A
( o3 e# s, r! T# H# @研究者在临床试验基线和过程中检测了入组患者的血液辅酶Q10的含量极其变化。! m2 a8 W2 F" _+ P9 F  n. v

4 ?0 U) y- ?; j: I5 G“We measured the CoQ10 concentration in the 35 HGN-treated patients with stage IV lung cancer and investigated its association with OS. The cut-off value was found to be 0.985 µg/ml (ROC curve; AUC=0.803, Sensitivity=83.3%, Specificity=81.8%, (Fig. 2E). Further, the 35 HGN-treated patients were stratified as having high (>0.985 µg/ml) and low (<0.985 µg/ml) CoQ10 concentrations. There were no significant differences in the clinico-pathological factors between patients with high and low CoQ10 (Table III). Patients with high CoQ10 had a significantly longer OS than those with low CoQ10 (Fig. 2F). MST of patients with high CoQ10 was 25 months, while that of patients with low CoQ10 was 8 months (Fig. 2F).”
' e3 `3 M( i7 q& Z; Q0 e+ `9 a " v; \+ H# o, s1 x7 f
“Following hydrogen gas treatment, the concentration of CoQ10 was increased in 19 (46%) of 41 patients (Table IV). Hence, we proceeded to calculate the rate of change of CoQ10 by hydrogen gas treatment (CoQ10 ratio=CoQ10 concentration after treatment/CoQ10 concentration before treatment) and classified patients by high- and low-CoQ10 ratio using the cut-off value (1.175) (ROC curve; AUC=0.710, Sensitivity=75.0%, Specificity=66.7%) (Fig. 2G). Patients with a high-CoQ10 ratio survived significantly longer than those with a low-CoQ10 ratio, as shown in Fig. 2H. MST of patients with a high CoQ10 ratio was NR (not reached to 50% overall survival), while that of patients with low CoQ10 was 9 months (Fig. 2H).”# r) x2 p' I0 i

& B7 l' J% |& v0 R( t3 c血液辅酶Q10浓度高的患者,用icb的OS更长。* z& I6 D3 Q% v3 v6 r* w

1条精彩回复,最后回复于 2025-4-13 18:41

社区社区  高中二年级 发表于 2025-4-13 18:41:26 来自手机 | 显示全部楼层 来自: 中国
Cdkn2a求大神搞个科普

举报 使用道具

回复 支持 反对

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

  • 回复
  • 转播
  • 评分
  • 分享
帮助中心
网友中心
购买须知
支付方式
服务支持
资源下载
售后服务
定制流程
关于我们
关于我们
友情链接
联系我们
关注我们
官方微博
官方空间
微信公号
快速回复 返回顶部 返回列表